Biotech News
Repare Therapeutics Announces Six Abstracts Accepted for Presentation at AACR Annual Meeting 2025
ir.reparerx.com2026-05-06 15:28 EST
CAMBRIDGE, Mass. & MONTREAL --(BUSINESS WIRE)--Apr. 25, 2025-- Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced the acceptance of two abstracts for mini-oral presentation and the acceptance of four abstracts